{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:42:54Z","timestamp":1770745374158,"version":"3.49.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2590,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vancomycin is commonly used to treat resistant bacterial infections in people. Reported adverse effects of vancomycin in people include acute kidney injury (AKI), neutropenia, and systemic allergic reaction. Given the increased incidence of vancomycin-resistant bacterial infections in people, support is growing for restriction of vancomycin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the use of intravenous (IV) vancomycin in a university teaching hospital and to describe potential adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty-nine dogs and 7 cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medical records of dogs and cats treated with IV vancomycin at the Foster Hospital for Small Animals between January 2003 and October 2017 were reviewed. Information recorded included signalment, infection source, vancomycin dosing, potential adverse effects, and outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Vancomycin was used to treat infections from a range of sources with a variety of dosing intervals. The most common bacterial isolates susceptible to vancomycin included Enterococcus sp. (11\/36, 30.6%), methicillin-resistant Staphylococcus aureus (8\/36, 22.2%), and methicillin-resistant Staphylococcus pseudintermedius (2\/36, 5.6%). AKI occurred in 6 of 36 patients (16.7%) during vancomycin treatment but could not definitively be attributed to vancomycin treatment in any patients because of illness severity, additional nephrotoxic treatments, or both. Neutropenia or allergic reaction was not documented in any animal. In 2 of 36 patients (5.6%), susceptibility data documented an infection that was only susceptible to vancomycin. Most patients survived to discharge (25\/36, 69.4%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Adverse effects attributable to vancomycin were infrequent in dogs and cats. In most cases, there were potential alternative effective antimicrobials or lack of susceptibility data to support vancomycin treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.15357","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T04:24:48Z","timestamp":1543551888000},"page":"200-207","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Parenterally administered vancomycin in 29 dogs and 7 cats (2003-2017)"],"prefix":"10.1093","volume":"33","author":[{"given":"Ian M.","family":"DeStefano","sequence":"first","affiliation":[{"name":"Cummings School of Veterinary Medicine, Tufts University Department of Clinical Sciences, , North Grafton, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8910-4724","authenticated-orcid":false,"given":"Annie S.","family":"Wayne","sequence":"additional","affiliation":[{"name":"Cummings School of Veterinary Medicine, Tufts University Department of Clinical Sciences, , North Grafton, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3233-8930","authenticated-orcid":false,"given":"Elizabeth A.","family":"Rozanski","sequence":"additional","affiliation":[{"name":"Cummings School of Veterinary Medicine, Tufts University Department of Clinical Sciences, , North Grafton, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4925-4306","authenticated-orcid":false,"given":"Jonathan M.","family":"Babyak","sequence":"additional","affiliation":[{"name":"Cummings School of Veterinary Medicine, Tufts University Department of Clinical Sciences, , North Grafton, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,1,1]]},"reference":[{"key":"2026020922034092900_jvim15357-bib-0001","first-page":"798","article-title":"Saunders Handbook of Veterinary Drugs","author":"Papich","year":"2011","edition":"3rd"},{"key":"2026020922034092900_jvim15357-bib-0002","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.idc.2009.06.010","article-title":"Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin\/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin","volume":"23","author":"Nailor","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"2026020922034092900_jvim15357-bib-0003","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199401273300406","article-title":"Clostridium difficile colitis","volume":"330","author":"Kelly","year":"1994","journal-title":"N Engl J Med"},{"key":"2026020922034092900_jvim15357-bib-0004","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0924-8579(09)70008-1","article-title":"Clostridium difficile 30 years on: what has, or has not, changed and why?","volume":"33","author":"Gerding","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"2026020922034092900_jvim15357-bib-0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1051\/vetres:2001129","article-title":"Antimicrobial resistance in staphylococci from animals with particular reference to bovine S. aureus, porcine S. hyicus, and canine S. intermedius","volume":"32","author":"Werckenthin","year":"2001","journal-title":"Vet Res"},{"key":"2026020922034092900_jvim15357-bib-0006","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.tim.2017.05.011","article-title":"Transfer of antibiotic resistance in Staphylococcus aureus","volume":"25","author":"Haaber","year":"2017","journal-title":"Trends Microbiol"},{"key":"2026020922034092900_jvim15357-bib-0007","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/CMR.10.4.781","article-title":"Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications","volume":"10","author":"Chambers","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"2026020922034092900_jvim15357-bib-0008","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-3164.2006.00536.x","article-title":"Screening of Staphylococcus aureus, S. intermedius, and S. schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-2004)","volume":"17","author":"Morris","year":"2006","journal-title":"Vet Dermatol"},{"key":"2026020922034092900_jvim15357-bib-0009","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2460\/javma.230.2.221","article-title":"Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1,772 samples (2001-2005)","volume":"230","author":"Jones","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922034092900_jvim15357-bib-0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.vetmic.2006.01.004","article-title":"Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household","volume":"115","author":"Weese","year":"2006","journal-title":"Vet Microbiol"},{"key":"2026020922034092900_jvim15357-bib-0011","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/vde.12444","article-title":"Recommendations for approaches to methicillin-resistant staphylococcal infections of small animals: diagnosis, therapeutic considerations and preventative measures","volume":"28","author":"Morris","year":"2017","journal-title":"Vet Dermatol"},{"key":"2026020922034092900_jvim15357-bib-0012","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/AAC.32.6.848","article-title":"Vancomycin pharmacokinetics in patients with various degrees of renal function","volume":"32","author":"Rodvold","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020922034092900_jvim15357-bib-0013","first-page":"923","article-title":"The ICU Book","author":"Marino","year":"2014","edition":"4th"},{"key":"2026020922034092900_jvim15357-bib-0014","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2460\/javma.1994.204.04.602","article-title":"Administration of vancomycin for treatment of ascending bacterial cholangiohepatitis in a cat","volume":"204","author":"Jackson","year":"1994","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922034092900_jvim15357-bib-0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jfms.2005.01.001","article-title":"Vancomycin for multi-drug resistant Enterococcus faecium cholangiohepatitis in a cat","volume":"7","author":"Pressel","year":"2005","journal-title":"J Feline Med Surg"},{"key":"2026020922034092900_jvim15357-bib-0016","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2460\/ajvr.1988.49.09.1637","article-title":"Single- and multiple-dose pharmacokinetics of intravenously administered vancomycin in dogs","volume":"49","author":"Zaghlol","year":"1988","journal-title":"Am J Vet Res"},{"key":"2026020922034092900_jvim15357-bib-0017","first-page":"278","article-title":"Vancomycin for the treatment of methicillin-resistant staphylococcal and enterococcal infections in 15 horses","volume":"69","author":"Orsini","year":"2005","journal-title":"Can J Vet Res"},{"key":"2026020922034092900_jvim15357-bib-0018","first-page":"471","article-title":"Successful treatment of Corynebacterium urealyticum encrusting cystitis with systemic and intravesical antimicrobial therapy","volume":"56","author":"Raab","year":"2015","journal-title":"Can Vet J"},{"key":"2026020922034092900_jvim15357-bib-0019","first-page":"12","article-title":"A successful vancomycin treatment of multidrug-resistant MRSA-associated canine pyoderma","volume":"1","author":"Manzillo","year":"2016","journal-title":"J Dermatol Res Ther"},{"key":"2026020922034092900_jvim15357-bib-0020","first-page":"347","article-title":"Canine and Feline Infectious Diseases","author":"Sykes","year":"2014"},{"key":"2026020922034092900_jvim15357-bib-0021","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2460\/javma.233.4.565","article-title":"Issues regarding the use of vancomycin in companion animals","volume":"233","author":"Weese","year":"2008","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"2026020922034092900_jvim15357-bib-0022","first-page":"1","article-title":"Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"Morb Mortal Wkly Rep"},{"key":"2026020922034092900_jvim15357-bib-0023","doi-asserted-by":"crossref","first-page":"4C","DOI":"10.1155\/2006\/971352","article-title":"Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: a perspective for Canadian health care practitioners","volume":"17","author":"Barton","year":"2008","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2026020922034092900_jvim15357-bib-0024","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jvim.12562","article-title":"ACVIM consensus statement on therapeutic antimicrobial use in animals and antimicrobial resistance","volume":"29","author":"Weese","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020922034092900_jvim15357-bib-0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/vde.12444","article-title":"Recommendations for approaches to methicillin-resistant staphylococcal infections of small animals: diagnosis, therapeutic considerations and preventative measures. Clinical Consensus Guidelines of the World Association for Veterinary Dermatology","volume":"28","author":"Morris","year":"2017","journal-title":"Vet Dermatol"},{"issue":"1","key":"2026020922034092900_jvim15357-bib-0026","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1378\/chest.120.6.2059","article-title":"Infection control in the ICU","volume":"120","author":"Eggimann","year":"2001","journal-title":"Chest"},{"key":"2026020922034092900_jvim15357-bib-0027","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1532-950X.1997.tb01699.x","article-title":"Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs","volume":"26","author":"Hauptman","year":"1997","journal-title":"Vet Surg"},{"key":"2026020922034092900_jvim15357-bib-0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2460\/javma.249.1.65","article-title":"Epidemiology of systemic inflammatory response syndrome and sepsis in cats hospitalized in a veterinary teaching hospital","volume":"249","author":"Babyak","year":"2016","journal-title":"J Am Vet Med Assoc"},{"key":"2026020922034092900_jvim15357-bib-0029","article-title":"Internal Renal Interest Society (IRIS) website","author":"Grading of acute kidney injury","year":"2016"},{"key":"2026020922034092900_jvim15357-bib-0030","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid0702.010204","article-title":"The changing epidemiology of Staphylococcus aureus?","volume":"7","author":"Chambers","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2026020922034092900_jvim15357-bib-0031","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jac\/dkn372","article-title":"Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates","volume":"62","author":"Rehm","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2026020922034092900_jvim15357-bib-0032","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"issue":"1","key":"2026020922034092900_jvim15357-bib-0033","first-page":"224","article-title":"Clinical failure of vancomycin treatment of Staphylococcus aureus infection in a tertiary care hospital in southern Brazil","volume":"7","author":"Lutz","year":"2003","journal-title":"Braz J Infect Dis"},{"key":"2026020922034092900_jvim15357-bib-0034","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine"},{"key":"2026020922034092900_jvim15357-bib-0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0025-7125(16)30059-1","article-title":"Intra-abdominal sepsis","volume":"79","author":"Bartlett","year":"1995","journal-title":"Med Clin North Am"},{"key":"2026020922034092900_jvim15357-bib-0036","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11908-010-0138-8","article-title":"Treatment of resistant enterococcal urinary tract infections","volume":"12","author":"Swaminathan","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"2026020922034092900_jvim15357-bib-0037","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.0007-1323.2001.02023.x","article-title":"Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis","volume":"89","author":"Sitges-Serra","year":"2002","journal-title":"Br J Surg"},{"key":"2026020922034092900_jvim15357-bib-0038","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1345\/aph.1P583","article-title":"Vancomycin-induced neutropenia. Is it dose- or duration-related?","volume":"45","author":"Black","year":"2011","journal-title":"Ann Pharmacother"},{"key":"2026020922034092900_jvim15357-bib-0039","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/491708","article-title":"Vancomycin: a 50-year reassessment","volume":"42","author":"Moellering","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2026020922034092900_jvim15357-bib-0040","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020922034092900_jvim15357-bib-0041","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/CCM.0000000000002769","article-title":"Vancomycin plus piperacillin-tazobactam and acute kidney injury in adults: a systemic review and meta-analysis","volume":"46","author":"Luther","year":"2018","journal-title":"Crit Care Med"},{"key":"2026020922034092900_jvim15357-bib-0042","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/2042018816638223","article-title":"Review of vancomycin-induced renal toxicity: an update","volume":"7","author":"Bamgbola","year":"2016","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2026020922034092900_jvim15357-bib-0043","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"2026020922034092900_jvim15357-bib-0044","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health System Pharmacists, the Infectious Disease Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"2026020922034092900_jvim15357-bib-0045","article-title":"Antimicrobial stewardship definition and core principles","author":"American Veterinary Medical Association","year":"2018"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.15357","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/33\/1\/200\/66657753\/jvim15357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/33\/1\/200\/66657753\/jvim15357.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:05:21Z","timestamp":1770692721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/33\/1\/200\/8447860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.15357","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2019,1,1]]},"assertion":[{"value":"2018-05-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}